U.S. Markets closed

79% of Analysts Recommend a ‘Buy’ on Abbott Laboratories

Sarah Collins
79% of Analysts Recommend a ‘Buy’ on Abbott Laboratories

Abbott Laboratories (ABT) has a leading portfolio of products in its Nutrition, Diagnostics, Medical Devices, and Established Pharmaceuticals segments. The company reported stellar second-quarter earnings results on July 18. For more details, please read Abbott Laboratories’ Q2 Results: What Drove Its Robust Growth?